Evaluation and therapy of hypercalcemia.

Nadia Khoury, Kim A. Carmichael

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Hypercalcemia is a common but challenging disorder. It results from PTH-dependent or independent increased bone resorption, increased vitamin D-dependent absorption, or as a result of various drugs and substances. Outpatient hypercalcemia is most commonly caused by primary hyperparathyroidism while malignancy accounts for most inpatient disease. Treatment includes adequate hydration, intravenous bisphosphonates, and occasionally calcitonin as a temporizing measure. Treating the underlying cause, such as employing chemotherapy for malignancy or parathyroidectomy for hyperparathyroidism, is also essential.

Original languageEnglish
Pages (from-to)99-103
Number of pages5
JournalMissouri Medicine
Issue number2
StatePublished - Mar 1 2011


Dive into the research topics of 'Evaluation and therapy of hypercalcemia.'. Together they form a unique fingerprint.

Cite this